Welcome to ORIENTAL FARMACEUTICA
Laboratorios Oriental Farmacéutica starts its activities in 1968, introducing cutting edge technological advances in the development and production of pharmaceuticals products. Well-known brands such as Osteocalmine, Ranitul, Broncocalmine, Norflol were standards in the treatment of several primary care diseases.
Nowadays, biotechnology and the treatment of genetic diseases as well as effective responses to specific pathologies, represent - forty years later - the continuity of the same institutional spirit: Scientific Innovation.
Latest News
An Oriental Farmacéutica ICISA division
Oriental Farmaceutica Tobramicyn - A step forward in the treatment of Cystic Fibrosis. Oriental launches Oriental Farmaceutica Tobramicyn, the first and only single dose packed inhalatory tobramicyn. (more +)
Oriental has been designated by SciClone – leader in Biotechnology R&D – as its representative in Argentina.
SciClone’s Zadaxin (Thymalfasin) turns up to be the first Biopharmaceutical product in Oriental portfolio.
Oriental introduces Filgrastim Duncan. Filgrastim Duncan is a granulocyte colony-stimulating factor (G-CSF) analog used to stimulate the proliferation and differentiation of granulocytes.
